Instruments

Name Stock exchange Average volume Price Type
NAITO & CO., LTD. 7624

Japan Exchange

32,667 148 JPY Stock Naito & Co., Ltd. Stock

News (418)

Biogen : “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea PU
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status AQ
Transcript : Eisai Co., Ltd., 2024 Earnings Call, May 15, 2024
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status GL
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status PR
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA PR
Transcript : Eisai Co., Ltd. - Special Call
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected RE
EISAI INVESTS IN C2N TO SUPPORT SIMPLIFYING THE DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE TO BETTER SERVE PATIENT AQ
"LEQEMBI Intravenous Infusion"Lecanemab) for the Treatment of Alzheimer's Disease to be Launched in Japan on December 20 AQ
Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20 RE
Transcript : Eisai Co., Ltd. - Special Call
Biogen : “LEQEMBI® Intravenous Infusion” (Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20 PU
Transcript : Eisai Co., Ltd., Q2 2024 Earnings Call, Nov 07, 2023
EISAI PRESENTS NEW LEQEMBI INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER'S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AQ
Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional Analyses of Clarity AD at The Clinical Trials On Alzheimer’s Disease (CTAD) Conference GL
EISAI PRESENTS NEW LEQEMBI® (LECANEMAB-IRMB) INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER'S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE PR
Eisai : Latest Value Creation Report PU
Eisai Co., Ltd. - LEQEMBI Intravenous Infusion Approved for the Treatment of Alzheimer's disease in Japan AQ
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen AQ
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan AQ
UPDATE2: Japan approves Alzheimer's drug developed by Eisai, Biogen AQ
LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan GL
Eisai Presents Latest Analysis of Lecanemab's Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer's Association International Conference (AAIC) 2023 PR
Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023 GL
Eisai exec who helped steer Alzheimer's drug approval to leave RE
Eisai exec who helped steer Alzheimer's drug approval to retire in July RE
EISAI - FDA GRANTS TRADITIONAL APPROVAL FOR LEQEMBI FOR THE TREATMENT OF ALZHEIMER'S DISEASE AQ
UPDATE4: U.S. formally approves Alzheimer's drug developed by Japan's Eisai AQ
UPDATE3: U.S. formally approves Alzheimer's drug developed by Japan's Eisai AQ
Transcript : Eisai Co., Ltd. - Special Call
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease GL
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease AQ
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer's Disease PR
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease AQ
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease GL
Biogen : EISAI FILES MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER’S DISEASE IN SOUTH KOREA PU
Biogen : EISAI SUBMITS MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER’S DISEASE IN GREAT BRITAIN PU
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease GL
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer’s Disease AQ
Transcript : Eisai Co., Ltd., 2023 Earnings Call, May 15, 2023
Eisai : and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 Trials of LENVIMA® (lenvatinib) Plus KEYTRUDA® (pembrolizumab) in Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017) PU
ADDITIONAL DETAILED ANALYSES FROM PHASE 2 STUDY 201 OF LECANEMAB PUBLISHED AS THREE PAPERS IN PEER-REVIEWED JOURNALS PR
EISAI PRESENTED NEW ANALYSES OF ARIA AND QOL ON LECANEMAB IN CLARITY AD AT THE AD/PD™ 2023 ANNUAL MEETING PR
Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD/PD™ 2023 Annual Meeting GL
1234NextSee all

Companies (1)

NAITO & CO., LTD. 51 M $
Logo Naito & Co., Ltd.

Naito & Co Ltd is a Japan-based company mainly engaged in the sale of cutting tools, measurement, industrial equipment, machine tools and others. Cutting tools include drilling and chamfering tools, threading tools, milling tools, turning tools, and cutti ...


Insiders


Picture Haruo Naito
Haruo Naito

Haruo Naito holds the position of Chief Executive Officer & Representative Director at Eisai Co., Ltd. and Chairman at The Naito Foundation. Mr. Naito is also Chairman for The Naito Foundation.


Picture Tadaaki Naito
Tadaaki Naito

Presently, Tadaaki Naito holds the position of Chairman of Nippon Yusen KK. Mr. Naito is also on the board of Mitsubishi Logistics Corp. and World Shipping Council. Mr. Naito received an undergraduate degree from the University of Hitotsubashi.


Picture Hiroyasu Naito
Hiroyasu Naito

Presently, Hiroyasu Naito holds the position of Executive President & Representative Director at Rinnai Corp. He is also on the board of Nagoya Railroad Co., Ltd.


Picture Keisuke Naito
Keisuke Naito

Keisuke Naito has worked at Eisai Co., Ltd.
since 2013.
His current position is SVP, Chief Strategy, Planning & Ecosystem Officer.



Picture Katsuyuki Naito
Katsuyuki Naito

Katsuyuki Naito formerly worked at Chubu Electric Power Co., Inc., as Corporate Auditor from 1978 to 2012.
Mr. Naito received his graduate degree in 1978 from Waseda University.















Picture Kiyomi Naito
Kiyomi Naito

Kiyomi Naito worked as the Head of Architecture Technology Sales at Meiko Construction Co., Ltd.
from 2011 to 2012.


Picture Yusuke Naito
Yusuke Naito

Yusuke Naito is currently working as a Research Analyst at Ichiyoshi Research Institute, Inc. He previously worked as a Research Analyst at Citigroup Global Markets Japan, Inc.



Picture Tatsunobu Naito
Tatsunobu Naito

Tatsunobu Naito is currently the President and Representative Director at Obihiro Chuoseika KK since 1991.
He previously worked as an Outside Director at Daiichi Co., Ltd.





Picture Ryoichi Naito
Ryoichi Naito

Mr. Ryoichi Naito is a Strategist at SMBC Nikko Securities, Inc. Mr. Naito was previously employed as a Research Analyst by Nikko Citigroup Ltd.
and a Strategist by Citigroup Global Markets Japan, Inc.







Picture Hideyuki Naito
Hideyuki Naito

Hideyuki Naito has worked as an Auditor at Duskin Co., Ltd.
since 2020.


Picture Tatsuya Naito
Tatsuya Naito

Tatsuya Naito is currently working as an Auditor at Cybernet Systems Co., Ltd.
since 2010 and as a Member-Supervisory Board at FUJISOFT CHINA Corp.
since 2014.
Previously, he worked at Fuji Soft, Inc. as an Executive Officer, Head-Finance & Public Relations.


Picture Akinobu Naito
Akinobu Naito

Akinobu Naito has worked as an Independent Outside Director at Maruzen Showa Unyu Co., Ltd.
since 2011.







Picture Masahiko Naito
Masahiko Naito

Masahiko Naito currently works as a Senior Executive Officer & Manager-General Affairs at Pacific Metals Co., Ltd.







Picture Kunihiko Naito
Kunihiko Naito

Kunihiko Naito is currently a Director at Asia Pulp & Paper Co. Ltd., a Representative Director at NSN Global Partners Ltd., and a Representative Director at NSN Global (Singapore) Pte Ltd.
He previously worked as a Director at Sinarmas Land Ltd.
in 2006, and as an Independent Non-Executive Director from 2007 to 2020.
He also held positions as a General Manager-Machinery Department at Nissho Iwai Corp.
and as an Auditor at CONVUM Ltd.
Mr. Naito received his undergraduate degree from Waseda University in 1967.


Picture Yoshihiko Naito
Yoshihiko Naito

Yoshihiko Naito is a University Professor at Shokei Gakuen since 2011.
He previously worked as an Outside Director at Toell Co., Ltd.








Picture Seiji Naito
Seiji Naito

Seiji Naito is associated with Naito Tanzosho Co., Ltd.
since 2010 and currently holds the position of President & Representative Director.


Picture Agasa Naito
Agasa Naito

Agasa Naito has held the following positions in the past: Independent Outside Director at Nitto Boseki Co., Ltd.
starting in 2020, Independent Director at BOOKOFF Group Holdings Ltd.
starting in 2018, and Supervisory Officer at GLP J-REIT starting in 2022.
Ms. Naito's current job(s) include Independent Outside Director at Nitto Boseki Co., Ltd., Independent Director at BOOKOFF Group Holdings Ltd., and Supervisory Officer at GLP J-REIT.






Picture Takeshi Naito
Takeshi Naito

Takeshi Naito currently works as a Manager-Finance & Accounting at V Technology Co., Ltd.





Picture Noriyoshi Naito
Noriyoshi Naito

Noriyoshi Naito has a current job as an Executive Officer & Manager-Technology at Masuda Flour Milling Co., Ltd.










Picture Yoshiharu Naito
Yoshiharu Naito

Yoshiharu Naito currently works as a Director at SERENDIP Holdings Co. Ltd.


Picture Takashi Naito
Takashi Naito

Takashi Naito has worked as an Auditor at SB Technology Corp.
since 2018 and at SB Players Corp.
since 2016.
He is also currently an Executive Officer and GM-Finance & Accounting at SoftBank Corp.




Picture Yoshiyuki Naito
Yoshiyuki Naito

Yoshiyuki Naito is currently the Chief Executive Officer at Aijinkai Healthcare Corp.
and the Managing Director & GM-Headquarters Sales III at Shinden Hightex Corp.



Picture Hidejiro Naito
Hidejiro Naito

Hidejiro Naito is currently working as a Representative Director at Shumanagement KK since 2007.
Prior to this, he worked as the President & Representative Director at Shin Maint Holdings Co., Ltd.


Picture Tsuyoshi Naito
Tsuyoshi Naito

Tsuyoshi Naito is currently the President & Representative Director at Tesco Co. Ltd.
(Tokyo) since 2020.
He is also the Managing Director at Shin Maint Holdings Co., Ltd.
since 2019, the Representative Director at Shumanagement KK since 2018, and the Director at Shin Pro Maint, Inc. since 2017.
Previously, he worked as a Director at TNP Co., Ltd.



Picture Koji Naito
Koji Naito

Koji Naito currently works as an Executive Officer & Manager-Bulk at Toell Co., Ltd.




Picture Koji Naito
Koji Naito

Koji Naito has a current job as the President & Representative Director at Renascience, Inc.


Picture Osamu Naito
Osamu Naito

Osamu Naito has worked as an Auditor at Yuasa Funashoku Co., Ltd.
since 2020.


Picture Shoji Naito
Shoji Naito

Shoji Naito currently works at CreativeBank, Inc., as Chief Executive Officer.



Picture Seiichi Naito
Seiichi Naito

Seiichi Naito has a current job as the Chief Investment Manager at Angel Japan Asset Management KK.


Picture Naoki Naito
Naoki Naito

Naoki Naito currently works as a Director at The Institute of Energy Economics, Japan.


Picture Masahiko Naito
Masahiko Naito

Masahiko Naito has worked at TV Asahi Corp.
(New) since 1992.
His current job title is Director & Head-News Bureau, which he has held since 2022.





Picture Hiroshi Naito
Hiroshi Naito

Hiroshi Naito has a current job as a Director at Tokyo Kikai Seisakusho, Ltd.




Picture Kayoko Naito
Kayoko Naito

Kayoko Naito is currently a Supervisory Officer at Tokyo Infrastructure Energy Investment Corp.
She previously worked as an Independent Outside Director at Sojitz Corp.
Naito graduated from Columbia Law School in 1988.

No results for this search